Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new site revision entry v3.6.6 was added and the previous revision v3.6.5 was removed, indicating a minor platform update shown on the page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedPage revision label updated from v3.6.4 to v3.6.5. This indicates a newer version of the page was published, without changes to the displayed clinical trial information.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a new version of the page.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page revision tag changes from v3.6.2 to v3.6.3, reflecting a small template update. It does not alter the study details or how information is presented to users.SummaryDifference0.1%

- Check77 days agoChange DetectedA new page revision label, v3.6.2, has been added. The previous revision label, v3.6.0, was removed, indicating an update to the page content.SummaryDifference0.1%

- Check91 days agoChange DetectedA recruitment status notice 'No longer looking for participants' was added, indicating the study is not enrolling. New help and navigation items—'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'—were added, and the 'Intervention / Treatment' heading was reformatted to 'Intervention/Treatment' while the old 'Revision: v3.5.5' note was removed in favor of 'Revision: v3.6.0'.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.